Prebiotics and Probiotics for Health Promotion
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Cell Biology and Pathology".
Deadline for manuscript submissions: closed (15 October 2022) | Viewed by 295
Special Issue Editors
Interests: human microbiota; probiotics; H. pylori; SARS-CoV-2; oncogenesis; history of medicine
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
In recent years, there has been an increased interest in the scientific community concerning the microbiota and its relationship with health and disease. Studies regarding the therapeutic potential of restoring dysbiosis as a treatment for common diseases have shown that the administration of prebiotics and probiotics, in combination or separately, is both simple and accessible.
Many researchers have demonstrated the effectiveness of pre- and pro-biotics in promoting health or treating certain morbidities (i.e., COVID-19, H. pylori infection, vaginosis, etc.); however, concerns have been raised regarding the possible risks of administrating probiotics.
Prebiotics are simple nutrients that, when degraded by the gut microbiota, produce metabolic molecules that act locally, regulating the microbial communities, or can enter into the bloodstream, reaching distant tissues and affecting their physiology.
This Special Issue aims to promote the research and discussion regarding the current knowledge of probiotics/prebiotics, their potential clinical applications, and their possible side effects.
Dr. Luigi Santacroce
Dr. Lucrezia Bottalico
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- human microbiota
- probiotics
- H. pylori
- SARS-CoV-2
- oncogenesis
- history of medicine
